全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Tsunenori Kondo , Toshio Takagi ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (4), pp.767-773Springer
摘要:The clinical benefit of targeted molecular therapy (TMT) for an inferior vena cava (IVC) tumor thrombus associated with renal cell carcinoma (RCC) is unclear. The aim of the present study was to assess the change in IVC thrombus height during TMT and to identify the factors assoc...
作者:Tsunenori Kondo , Yoji Nagashima ...
来源:[J].European Radiology(IF 3.548), 2017, Vol.27 (11), pp.4866-4873Springer
摘要:We evaluated 18F-fluorodeoxyglucose (FDG) uptake by renal cell carcinomas (RCCs) to determine whether different histological subtypes and Fuhrman grades can be distinguished.
作者:Tsunenori Kondo , Hiroki Ishihara ...
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2019, Vol.17 (4), pp.e772-e778Elsevier
摘要:Abstract(#br)Introduction(#br)There is scarce information regarding nivolumab treatment for metastatic renal cell carcinoma (mRCC) in patients with end-stage renal disease (ESRD). This study investigated the safety and efficacy of nivolumab in patients with mRCC and ESRD.(#br)Mat...
作者:Tsunenori Kondo , Kazuhiko Yoshida ...
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2017Elsevier
摘要:Abstract(#br)Background(#br)The usefulness of the aspartate transaminase (AST)/alanine transaminase (ALT) ratio (De Ritis ratio) as a predictive biomarker for patients with metastatic renal cell carcinoma (mRCC) undergoing cytoreductive nephrectomy (CN) remains unclear.(#br)Patie...
作者:Tsunenori Kondo , Kazuhiko Yoshida ...
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2017, Vol.15 (4), pp.495-501Elsevier
摘要:Abstract(#br)Background(#br)The role of systemic inflammatory markers, including C-reactive protein (CRP), the neutrophil/lymphocyte ratio (NLR), and the platelet/lymphocyte ratio (PLR), in predicting survival for patients with metastatic renal cell carcinoma receiving second-lin...
作者:Tsunenori Kondo , Shotaro Nakanishi ...
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2018Elsevier
摘要:Abstract(#br)Background(#br)Standard treatments have not been established in metastatic papillary renal cell carcinoma (mPRCC). We aimed to investigate treatment outcomes in patients with mPRCC.(#br)Methods(#br)This study included 51 patients who were diagnosed with PRCC in ...
作者:Tsunenori Kondo , Isao Hara ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (1), pp.145-152Springer
摘要:Abstract(#br) Background(#br)Our previous nonrandomized prospective study showed that template-based lymphadenectomy improved survival among patients with renal pelvic cancer but not among patients with ureteral cancer. However, regional node sites vary according to the tumo...
作者:Tsunenori Kondo , Kenji Omae ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (1), pp.126-135Springer
摘要:Abstract(#br) Background(#br)To evaluate the association between the timing of best tumor shrinkage (bTS) and metastatic renal cell carcinoma (mRCC) patient survival after first-line tyrosine kinase inhibitor (TKI) therapy.(#br) Methods(#br)The tumors of 91 patients with mRC...
作者:Tsunenori Kondo , Kazunari Tanabe ...
来源:[J].The AAPS Journal(IF 4.386), 2017, Vol.19 (1), pp.286-297Springer
摘要:Abstract(#br)Oseltamivir (Tamiflu®) is a prodrug of Ro 64-0802, a selective inhibitor of influenza virus neuraminidase. There is a possible relationship between oseltamivir treatment and neuropsychiatric adverse events; although this has not been established, close monitorin...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×